| 301 |
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
|
2015 |
| 302 |
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
|
2015 |
| 303 |
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
|
2015 |
| 304 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY |
2015 |
| 305 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY. |
2015 |
| 306 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY. |
2015 |
| 307 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY. |
2015 |
| 308 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY. |
2015 |
| 309 |
The Impact of Different TP53 Mutations on Outcome in Patients with Myelodysplastic Syndromes (MDS) |
2015 |
| 310 |
Deferasirox versus Deferoxiamine for the Treatment of Transfusional Iron Overload in Patients with β-Thalassemia Major
|
2014 |
هل لديك سؤال ؟
